metformin has been researched along with Cancer of the Ureter in 1 studies
Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Rieken, M | 1 |
Xylinas, E | 1 |
Kluth, L | 1 |
Trinh, QD | 1 |
Lee, RK | 1 |
Fajkovic, H | 1 |
Novara, G | 1 |
Margulis, V | 1 |
Lotan, Y | 1 |
Martinez-Salamanca, JI | 1 |
Matsumoto, K | 1 |
Seitz, C | 1 |
Remzi, M | 1 |
Karakiewicz, PI | 1 |
Scherr, DS | 1 |
Briganti, A | 1 |
Kautzky-Willer, A | 1 |
Bachmann, A | 1 |
Shariat, SF | 1 |
1 other study available for metformin and Cancer of the Ureter
Article | Year |
---|---|
Diabetes mellitus without metformin intake is associated with worse oncologic outcomes after radical nephroureterectomy for upper tract urothelial carcinoma.
Topics: Aged; Carcinoma, Transitional Cell; Diabetes Mellitus; Female; Follow-Up Studies; Humans; Hypoglycem | 2014 |